Biotoscana Investments S.A. announced earnings results for the third quarter of 2018. For the quarter, the company reported that net revenues increased by 2% in constant currency, also impacted by discontinued business and SOLVADI®, marking BRL 829 million LTM (including hyperinflation adjustment).  Adjusted EBITDA grew by 34% in constant currency against third quarter of 2017. Net income totaled BRL 13 million in third quarter of 2018 (including hyperinflation adjustment) from a loss of BRL 8 million in third quarter of 2017. Adjusted net income up 82% from third quarter of 2017, in constant currency.